A framework is proposed to guide the prioritization of cancer screening in settings with limited resources. The core idea emphasizes that screening programs should not assume universal applicability or uniform benefit.
First, not all cancers are suitable for population-level screening, implying that target cancer types should be selected based on factors such as achievable risk reduction, test characteristics, and resource implications. Second, not all individuals require screening; prioritization may rely on stratification by risk, age, or other criteria to optimize impact and efficiency.
Third, not all high-performance screening technologies are appropriate for population screening; evaluation should consider feasibility, cost, and implementation constraints alongside performance metrics. The article notes the need to balance potential mortality reduction against resource use, and to avoid overuse or misallocation of limited capacity.
Details such as specific criteria for cancer selection, risk stratification methods, or technology thresholds are not provided in the summary available. Uncertainty remains regarding exact operational parameters, so explicit guidance on implementation is not described here.